LGALS3 and type 2 diabetes mellitus: Tan et al. observed that individuals in the highest quartile of serum Gal-3 (>9.73 ng/mL) had significantly elevated risk for cardiovascular endpoints and all-cause mortality; however, it only concerned patients with type 2 diabetes [27].